Tahir Sheikh

CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons <i>In vitro</i> and <i>In vivo</i>

Archie Tse, Katherine G. Rendahl, Tahir Sheikh et al. · Clinical Cancer Research · 2007 · 149 citations

Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase

Samuel McNeely, Chiara Conti, Tahir Sheikh et al. · Cell Cycle · 2010 · 98 citations · Full text

Drug Synergy Screen and Network Modeling in Dedifferentiated Liposarcoma Identifies CDK4 and IGF1R as Synergistic Drug Targets

Martin L. Miller, Evan Molinelli, Jayasree S. Nair et al. · Science Signaling · 2013 · 88 citations

Drug Target, Engineering, Aggressive Cancer +17

Continuous Versus Interrupted Sutures for Primary Cleft Palate Repair

Ghulam Qadir Fayyaz, Nauman Ahmad Gill, Iftikhar Alam et al. · Plastic & Reconstructive Surgery Global Open · 2018 · 69 citations · Full text

A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors

Archie Tse, David S. Klimstra, Mithat Gönen et al. · Clinical Cancer Research · 2008 · 58 citations · Full text